The nice thing about Lexaria is that the business plan is not hinged on getting a Health canada stamp of approval on a grow-op. Chris Bunka has a plan that is now in full swing. CBD's in the US market is vitually untapped and the Tea product is a good tasting alternative medicine source that is about to hit the mainstream end user.

LXX has now see over 7 million in accumulation by its own CEO. I have never seen confidence like this in his own company and the plan going forward. Bunka has raised the bar for everyone else.

CONTENT POSTED ON THIS BLOG DOES NOT CONSTITUTE A BUY OR SELL RECOMMENDATION. MANY OF THE COMPANIES PROFILED HERE I AM NOT INVESTED IN AND DO NOT INTEND TO INVEST IN. THESE ARE MERELY MY THOUGHTS ON MARKET CONDITIONS AND STOCK VALUATIONS. INVESTING IN THE STOCK MARKET CAN BE VERY RISKY AND YOU SHOULD ALWAYS CONSULT AN INVESTMENT PROFESSIONAL BEFORE MAKING ANY DECISIONS. ULTIMATELY YOU ARE RESPONSIBLE FOR CONDUCTING YOUR OWN DUE DILIGENCE AND PROTECTING YOUR MONEY.